Cargando…
Multiple Myeloma Therapy: Emerging Trends and Challenges
SIMPLE SUMMARY: Multiple myeloma (MM) is a frequent hematological malignancy characterized by the uncontrolled growth of clonal plasma cells, primarily in the bone marrow. Over the past years, novel therapies have been discovered and introduced into clinical practice that have dramatically changed t...
Autores principales: | Dima, Danai, Jiang, Dongxu, Singh, Divya Jyoti, Hasipek, Metis, Shah, Haikoo S., Ullah, Fauzia, Khouri, Jack, Maciejewski, Jaroslaw P., Jha, Babal K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454959/ https://www.ncbi.nlm.nih.gov/pubmed/36077618 http://dx.doi.org/10.3390/cancers14174082 |
Ejemplares similares
-
Therapeutic Targeting of Protein Disulfide Isomerase PDIA1 in Multiple Myeloma
por: Hasipek, Metis, et al.
Publicado: (2021) -
Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network
por: Gu, Xiaorong, et al.
Publicado: (2020) -
Management of Relapsed–Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice
por: Dima, Danai, et al.
Publicado: (2023) -
Eltrombopag inhibits TET dioxygenase to contribute to hematopoietic stem cell expansion in aplastic anemia
por: Guan, Yihong, et al.
Publicado: (2022) -
A machine learning model of response to hypomethylating agents in myelodysplastic syndromes
por: Radakovich, Nathan, et al.
Publicado: (2022)